Persistence of effect of galcanezumab in patients with episodic or chronic migraine: phase 3, randomized, double-blind, placebo controlled EVOLVE-1, EVOLVE-2 and REGAIN studies

被引：0
|
作者：
Aurora, Sheena K. [1 ]
Zhang, Qi [1 ]
Stauffer, Virginia L. [1 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
JOURNAL OF HEADACHE AND PAIN | 2018年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
O18
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2)
    Silberstein, Stephen D.
    Stauffer, Virginia L.
    Day, Katie A.
    Lipsius, Sarah
    Wilson, Maria-Carmen
    JOURNAL OF HEADACHE AND PAIN, 2019, 20 (1):
  • [22] Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2)
    Stephen D. Silberstein
    Virginia L. Stauffer
    Katie A. Day
    Sarah Lipsius
    Maria-Carmen Wilson
    The Journal of Headache and Pain, 2019, 20
  • [23] Efficacy of galcanezumab for migraine prevention in patients with a medical history of anxiety and/or depression: a post hoc analysis of the phase 3, randomized, double-blind, placebo-controlled REGAIN, and pooled EVOLVE-1 and EVOLVE-2 studies (vol 60, pg 2202, 2020)
    Smitherman, T. A.
    HEADACHE, 2022, 62 (01): : 114 - 116
  • [24] Efficacy of galcanezumab in patients who failed prior preventive treatments for migraine: results from EVOLVE-1, EVOLVE-2 and REGAIN studies
    Dell'Agnello, Grazia
    Tockhorn-Heidenreich, Antje
    Zhang, Qi
    Ruff, Dustin D.
    Pearlman, Eric M.
    Aurora, Sheena K.
    Ford, Janet H.
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [25] EFFECT OF GALCANEZUMAB ON POSSIBLE MENSTRUAL-RELATED MIGRAINE: EXPLORATORY ANALYSES RESULTS FROM EVOLVE-1, EVOLVE-2 AND REGAIN
    Fernandes, M. F. S.
    Detke, H. C.
    Zhang, Q.
    Pavlovic, J. M.
    Aurora, S.
    CEPHALALGIA, 2018, 38 : 97 - 98
  • [26] Effect of galcanezumab on possible menstrual-related migraine: exploratory analyses results from EVOLVE-1, EVOLVE-2 and REGAIN
    Fernandes, Maria S.
    Detke, Holland C.
    Zhang, Qi
    Pavlovic, Jelena M.
    Aurora, Sheena K.
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [27] Correction to: Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2)
    Stephen D. Silberstein
    Virginia L. Stauffer
    Katie A. Day
    Sarah Lipsius
    Maria-Carmen Wilson
    The Journal of Headache and Pain, 2019, 20
  • [28] Phase 3 Studies (EVOLVE-1 & EVOLVE-2) of Galcanezumab in Episodic Migraine: Subgroup Analyses of Efficacy by Low-Versus High-Frequency of Migraine Headaches
    Silberstein, Stephen
    Stauffer, Virginia L.
    Day, Kathleen A.
    Lipsius, Sarah
    Wilson, Maria-Carmen
    NEUROLOGY, 2019, 92 (15)
  • [29] Effect of galcanezumab in women with episodic migraine meeting criteria for menstrually related migraine: A post hoc analysis of EVOLVE-1 and EVOLVE-2
    Macgregor, E. Anne
    Okonkwo, Rose
    Detke, Holland C.
    Polavieja, Pepa
    Fernandes, Maria S.
    Pavlovic, Jelena M.
    HEADACHE, 2024, 64 (02): : 179 - 187
  • [30] Phase 3 studies (EVOLVE-1 & EVOLVE-2) of galcanezumab in episodic migraine: subgroup analyses of efficacy by low-versus high-frequency of migraine headaches
    Silberstein, Stephen
    Stauffer, Virginia L.
    Day, Katie
    Zhang, Qi
    Lipsius, Sarah
    Wilson, Maria-Carmen
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
12345